Related Experiment Video
Updated: May 26, 2025

03:53
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
1.4K
Neuropathic Pain Following Surgery for Malignant Peripheral Nerve Sheath Tumors
Floris V Raasveld1,2,3, Tareq Hanna2, Fernando J Pacheco2
1Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Annals of Surgical Oncology
|February 22, 2025
Summary
Malignant peripheral nerve sheath tumors (MPNSTs) frequently cause neuropathic pain after resection, impacting quality of life. Improved pain management and nerve-sparing techniques are crucial for MPNST patients.
Area of Science:
- Oncology
- Surgical Oncology
- Pain Management
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with challenging surgical management.
- Understanding MPNST distribution, survival factors, and post-resection neuropathic pain is critical.
Purpose of the Study:
- To analyze the anatomic distribution of MPNSTs.
- To identify survival predictors in MPNST patients.
- To determine the prevalence of neuropathic pain and its effect on quality of life (QoL) post-MPNST resection.
Main Methods:
- Retrospective analysis of 119 patients undergoing MPNST resection.
- Cross-sectional survey of 39 survivors assessing neuropathic pain (NRS, s-DN4) and QoL (EQ-5D-5L).
Main Results:
- MPNSTs most commonly affect the lower extremity (42.9%).
- Female sex and absence of metastases were linked to lower mortality odds.
- 82.1% of survivors reported neuropathic pain, with significantly lower QoL scores compared to the general population.
Conclusions:
- High neuropathic pain prevalence post-MPNST resection significantly impairs QoL.
- Consideration of nerve-sparing/reconstructive techniques is recommended.
- Future research should focus on pain risk factors and preventive strategies for MPNST survivors.
Keywords:
En bloc excisionMalignant peripheral nerve sheath tumorNeuropathic painSurvivalTargeted muscle reinnervation
